Filing Details
- Accession Number:
- 0001179110-18-012211
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-16 18:46:29
- Reporting Period:
- 2018-10-12
- Accepted Time:
- 2018-10-16 18:46:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1034842 | Rigel Pharmaceuticals Inc | RIGL | Pharmaceutical Preparations (2834) | 943248524 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1725908 | Nelson Cabatuan | Rigel Pharmaceuticals, Inc. 1180 Veterans Blvd. South San Francisco CA 94080 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-10-12 | 10,000 | $3.12 | 58 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 5, 2018.
- Includes Reporting Person's purchases of 5,000 shares on December 29, 2017 and 5,000 shares on June 26, 2018 under the Issuer's Employee Stock Purchase Plan.